SUPN Price / Book | SUPERNUS PHARMACEUTICALS, INC.

SUPERNUS PHARMACEUTICALS, INC. (SUPN) Price / Book

2026-09-03: Price/Book Ratio 2.48.
2026-06-30: Price/Book Ratio 2.62.
2026-03-31: Price/Book Ratio 2.79.
2025-12-31: Price/Book Ratio 2.69.

Historical market capitalization divided by filed shareholder equity.

Available history: 2012-06-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	2.48
2026-06-30	2.62
2026-03-31	2.79
2025-12-31	2.69
2025-09-30	2.6
2025-06-30	1.66
2025-03-31	1.78
2024-12-31	1.95
2024-09-30	1.71
2024-06-30	1.54
2024-03-31	2.01
2023-12-31	1.72
2023-09-30	1.64
2023-06-30	1.77
2023-03-31	2.15
2022-12-31	2.18
2022-09-30	2.11
2022-06-30	1.83
2022-03-31	2.08
2021-12-31	1.9
2021-09-30	1.74
2021-06-30	2.07
2021-03-31	1.83
2020-12-31	1.79
2020-09-30	1.55
2020-06-30	1.88
2020-03-31	1.54
2019-12-31	2.09
2019-09-30	2.59
2019-06-30	3.32
2019-03-31	3.82
2018-12-31	3.84
2018-09-30	6.24
2018-06-30	8
2018-03-31	6.72
2017-12-31	7.65
2017-09-30	8.15
2017-06-30	9.53
2017-03-31	7.63
2016-12-31	6.58
2016-09-30	7.07
2016-06-30	7.15
2016-03-31	5.88
2015-12-31	7.48
2015-09-30	6.24
2015-06-30	8.04
2015-03-31	6.07
2014-12-31	8.76
2014-09-30	5.64
2014-06-30	13.83
2014-03-31	12.96
2013-12-31	9.01
2013-09-30	18.21
2013-06-30	5.55
2013-03-31	4.21
2012-12-31	3.81
2012-09-30	11.47
2012-06-30	6.03

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Immunome Inc. (IMNM)	United States	$2.538B	-9.45
Disc Medicine, Inc. (IRON)	United States	$2.553B	-11.40
Nurix Therapeutics, Inc. (NRIX)	United States	$2.457B	-5.39
SELLAS Life Sciences Group, Inc. (SLS)	United States	$2.420B	-91.87
uniQure N.V. (QURE)		$2.416B	-4.93
Vera Therapeutics, Inc. (VERA)	United States	$2.402B	-7.67
Harmony Biosciences Holdings, Inc. (HRMY)	United States	$2.399B	11.67
MBX Biosciences, Inc. (MBX)	United States	$2.664B	-25.36
Mineralys Therapeutics, Inc. (MLYS)	United States	$2.353B	-6.82
Viridian Therapeutics, Inc.\DE (VRDN)	United States	$2.342B	-5.38